The combination of elevated BNP and AF as a predictor of no early recanalization after IV-t-PA in acute ischemic stroke

Journal of the Neurological Sciences

Volumn 290, Issue 1-2, 2010, Pages 37-40

  Kimura, Kazumi ^a   Shibazaki, Kensaku ^a   Iguchi, Yasuyuki ^a   Aoki, Junya ^a   Sakai, Kenichiro ^a   Sakamoto, Yuki ^a   Kobayashi, Kazuto ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

AF; BNP; MRA; Recanalization; Tissue plasminogen activator (t PA)

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; BRAIN BLOOD FLOW; CEREBROVASCULAR ACCIDENT; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; RECANALIZATION;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; BRAIN; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; FEMALE; FIBRINOLYTIC AGENTS; HEART FAILURE; HUMANS; INTRACRANIAL EMBOLISM; MALE; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; STROKE; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT FAILURE; UP-REGULATION;

EID: 74849102918     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.11.014     Document Type: Article

References (21)

1. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581-1587.
2. Zangerle A., Kiechl S., Spiegel M., Furtner M., Knoflach M., Werner P., et al. Recanalization after thrombolysis in stroke patients: predictors and prognostic implications. Neurology 68 (2007) 39-44
3. Rubiera M., Alvarez-Sabin J., Ribo M., Montaner J., Santamarina E., Arenillas J.F., et al. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke. Stroke 36 (2005) 1452-1456
4. Molina C.A., Alexandrov A.V., Demchuk A.M., Saqqur M., Uchino K., and Alvarez-Sabin J. Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator. Stroke 35 (2004) 151-156
5. Alexandrov A.V., Demchuk A.M., Felberg R.A., Christou I., Barber P.A., Burgin W.S., et al. High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2-MHz transcranial Doppler monitoring. Stroke 31 (2000) 610-614
6. McDonagh T.A., Robb S.D., Murdoch D.R., Morton J.J., Ford I., Morrison C.E., et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 351 (1998) 9-13
7. Nakamura M., Endo H., Nasu M., Arakawa N., Segawa T., and Hiramori K. Value of plasma b type natriuretic peptide measurement for heart disease screening in a Japanese population. Heart 87 (2002) 131-135
8. Tsutamoto T., Wada A., Maeda K., Hisanaga T., Maeda Y., Fukai D., et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 96 (1997) 509-516
9. Yamamoto K., Burnett Jr. J.C., Jougasaki M., Nishimura R.A., Bailey K.R., Saito Y., et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 28 (1996) 988-994
10. Shibazaki K., Kimura K., Iguchi Y., Okada Y., and Inoue T. Plasma brain natriuretic peptide can be a biological marker to distinguish cardioembolic stroke from other stroke types in acute ischemic stroke. Intern Med 48 (2009) 259-264
11. Caplan L.R., and Hennerici M. Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. Arch Neurol 55 (1998) 1475-1482
12. Kimura K., Iguchi Y., Yamashita S., Shibazaki K., Kobayashi K., and Inoue T. Atrial fibrillation as an independent predictor for no early recanalization after IV-t-PA in acute ischemic stroke. J Neurol Sci 267 (2008) 57-61
13. Bakowski D., Wozakowska-Kaplon B., and Opolski G. The influence of left ventricle diastolic function on natriuretic peptides levels in patients with atrial fibrillation. Pacing Clin Electrophysiol 32 (2009) 745-752
14. Shimizu H., Murakami Y., Inoue S., Ohta Y., Nakamura K., Katoh H., et al. High plasma brain natriuretic polypeptide level as a marker of risk for thromboembolism in patients with nonvalvular atrial fibrillation. Stroke 33 (2002) 1005-1010
15. Shibazaki K., Kimura K., Okada Y., Iguchi Y., Terasawa Y., and Aoki J. Heart failure may be associated with the onset of ischemic stroke with atrial fibrillation: a brain natriuretic peptide study. J Neurol Sci 281 (2009) 55-57
16. Yamaguchi T., Mori E., Minematsu K., Nakagawara J., Hashi K., Saito I., et al. Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT). Stroke 37 (2006) 1810-1815
17. Albanese M.A., Clarke W.R., Adams Jr. H.P., and Woolson R.F. Ensuring reliability of outcome measures in multicenter clinical trials of treatments for acute ischemic stroke. The program developed for the trial of org 10172 in acute stroke treatment (TOAST). Stroke 25 (1994) 1746-1751
18. Davis M., Espiner E., Richards G., Billings J., Town I., Neill A., et al. Plasma brain natriuretic peptide in assessment of acute dyspnoea. Lancet 343 (1994) 440-444
19. del Zoppo G.J., Poeck K., Pessin M.S., Wolpert S.M., Furlan A.J., Ferbert A., et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 32 (1992) 78-86
20. Furst G., Saleh A., Wenserski F., Malms J., Cohnen M., Aulich A., et al. Reliability and validity of noninvasive imaging of internal carotid artery pseudo-occlusion. Stroke 30 (1999) 1444-1449
21. Smith W.S., Sung G., Starkman S., Saver J.L., Kidwell C.S., Gobin Y.P., et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 36 (2005) 1432-1438